SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001193125-19-164149
Filing Date
2019-06-03
Accepted
2019-06-03 16:33:22
Documents
12

Document Format Files

Seq Description Document Type Size
1 F-1 d708154df1.htm F-1 815434
2 EX-1.1 d708154dex11.htm EX-1.1 219587
3 EX-5.1 d708154dex51.htm EX-5.1 49123
4 EX-10.1 d708154dex101.htm EX-10.1 706454
5 EX-23.1 d708154dex231.htm EX-23.1 1439
6 GRAPHIC g708154g01u34.jpg GRAPHIC 38842
7 GRAPHIC g708154g08g08.jpg GRAPHIC 206751
8 GRAPHIC g708154g1002070541820.jpg GRAPHIC 2347
9 GRAPHIC g708154g18p88.jpg GRAPHIC 115220
10 GRAPHIC g708154g19u99.jpg GRAPHIC 143868
11 GRAPHIC g708154g25h30.jpg GRAPHIC 9175
12 GRAPHIC g708154g28u77.jpg GRAPHIC 152680
  Complete submission text file 0001193125-19-164149.txt   2714742
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000
Type: F-1 | Act: 33 | File No.: 333-231916 | Film No.: 19873720
SIC: 2836 Biological Products, (No Diagnostic Substances)